The global medical device adhesive market is projected to reach USD 3.20 billion by 2021, at a CAGR of 6.6% from 2016 to 2021. The market is mainly driven by the increase in the global population with a rise in income level, high growth of the implantable and wearable device market, expansion activities of medical device manufacturers, and high prevalence of chronic diseases.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6819883
New product launch is the key strategy adopted by the major companies to cater to the changing medical device requirements as well as increase the market share in the medical device adhesive market. The market players adopted this organic growth strategy to increase their product portfolio and expand their global presence between 2013 and 2016. The companies focus on entering new markets by launching technologically advanced and innovative medical device adhesive for different technology systems. Some of the leading medical device adhesive manufacturers are Henkel AG & Co. (Germany), Dymax Corporation (U.S.), Permabond Engineering Adhesives Inc. (U.K.), H.B. Fuller Company (U.S.), Honle Group (Germany), and Masterbond Inc. (U.S.). These companies have adopted various organic and inorganic growth strategies to improve their product portfolio and increase their global market shares.
Companies have also been focusing on other strategies such as joint ventures, partnerships and agreements, and mergers & acquisitions during the last four years. These strategies together accounted for a share of 20% of all the strategic developments from 2013 to 2016.
Request for sample report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=6819883
North America was the most active region in terms of organic and inorganic strategic initiatives from 2013 to 2016. New product launches were the preferred strategy in this region. In March 2015 Dymax launched a new LED curable, fast curing adhesive, which is ideal for tight-tolerance needle-bonding applications. This new adhesive is blue in color for easy verification of placement when it is at an uncured state. As this adhesive initiates the curing process with sufficient exposure to UV light, it becomes colorless, indicating that adhesive is fully cured and the bond site secure. Similarly, in August 2015, Masterbond formulated adhesive for medical device applications for high-performance bonding, sealing, and coating. This system meets both United States Pharmacopeia (USP) biocompatibility and International Standards (ISO) cytotoxicity standards and resists a variety of sterilization techniques such as gamma radiation, EtO, and some types of liquid sterilants. The flexible system can also resist extremely severe thermal cycling as well as thermal and mechanical shock.
Dymax Corporation and Company and Honle Group are the most active players in the global medical device adhesive market. They accounted for the largest share of all the developmental activities undertaken in the medical device adhesive market between 2013 and 2016. As a part of its organic strategy, Dymax focuses on expanding its medical device adhesive portfolio by investing in new product launches, specifically, in North America.
Another company that has established a strong foothold in the medical device adhesive market is Panacol, a subsidiary of Honle Group (Germany). The company is focused on both, organic and inorganic growth strategies such as expansions, mergers & acquisitions, and partnerships. For instance, in 2015 Panacol signed an agreement with SKC Co. to open a joint venture in South Korea. Moreover, in 2015, the company (Panacol) took over the majority of Tangent Industries Inc. (Torrington, U.S.) which is an expert in developing Light-Curable UV Adhesives, Acrylates, and Epoxies that are used as adhesives, coatings, sealants, gaskets, and masks.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Address:630 Dundee Road Suite 430
Country: United States